Concepts (235)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lasers, Gas | 8 | 2024 | 103 | 4.280 |
Why?
|
Laser Therapy | 21 | 2024 | 1108 | 3.120 |
Why?
|
Skin | 26 | 2024 | 4489 | 2.150 |
Why?
|
Skin Aging | 6 | 2022 | 140 | 1.310 |
Why?
|
Lipectomy | 3 | 2022 | 114 | 1.280 |
Why?
|
Lasers, Solid-State | 2 | 2022 | 183 | 1.160 |
Why?
|
Papain | 1 | 2024 | 66 | 0.950 |
Why?
|
Urea | 1 | 2024 | 448 | 0.800 |
Why?
|
Debridement | 1 | 2024 | 495 | 0.780 |
Why?
|
Cryosurgery | 2 | 2022 | 479 | 0.770 |
Why?
|
Epidermis | 5 | 2024 | 538 | 0.760 |
Why?
|
Cutis Laxa | 1 | 2020 | 29 | 0.690 |
Why?
|
Hyperemia | 1 | 2021 | 224 | 0.670 |
Why?
|
Microvessels | 2 | 2021 | 591 | 0.660 |
Why?
|
Dermatology | 2 | 2022 | 907 | 0.650 |
Why?
|
Capillaries | 2 | 2019 | 755 | 0.650 |
Why?
|
Lasers, Semiconductor | 2 | 2009 | 44 | 0.640 |
Why?
|
Skin Ulcer | 2 | 2018 | 130 | 0.630 |
Why?
|
Tomography, Optical Coherence | 4 | 2021 | 2932 | 0.630 |
Why?
|
Acne Vulgaris | 2 | 2024 | 352 | 0.630 |
Why?
|
Angiography | 2 | 2021 | 1581 | 0.610 |
Why?
|
Chalcogens | 1 | 2018 | 3 | 0.610 |
Why?
|
Adipocytes | 2 | 2018 | 1194 | 0.590 |
Why?
|
Microcirculation | 1 | 2021 | 1280 | 0.520 |
Why?
|
Subcutaneous Fat | 3 | 2022 | 402 | 0.510 |
Why?
|
Cryotherapy | 3 | 2022 | 164 | 0.510 |
Why?
|
Lasers | 3 | 2017 | 951 | 0.490 |
Why?
|
Burns | 4 | 2024 | 1903 | 0.480 |
Why?
|
Neutrophil Infiltration | 1 | 2017 | 394 | 0.470 |
Why?
|
Hot Temperature | 3 | 2011 | 1433 | 0.450 |
Why?
|
NAD | 1 | 2018 | 619 | 0.450 |
Why?
|
Dermis | 4 | 2009 | 204 | 0.420 |
Why?
|
Photolysis | 2 | 2017 | 94 | 0.410 |
Why?
|
Phototherapy | 5 | 2007 | 370 | 0.410 |
Why?
|
Fibrin | 1 | 2015 | 513 | 0.410 |
Why?
|
Swine | 7 | 2024 | 5988 | 0.380 |
Why?
|
Immunity | 1 | 2017 | 1002 | 0.380 |
Why?
|
Immunity, Cellular | 1 | 2017 | 1555 | 0.370 |
Why?
|
Fibroblasts | 3 | 2011 | 4159 | 0.360 |
Why?
|
Microscopy, Fluorescence | 1 | 2018 | 2627 | 0.360 |
Why?
|
Antigens, Neoplasm | 2 | 2021 | 2002 | 0.350 |
Why?
|
Bystander Effect | 1 | 2011 | 90 | 0.350 |
Why?
|
Surgery, Plastic | 1 | 2017 | 651 | 0.340 |
Why?
|
Carbon Dioxide | 3 | 2024 | 1137 | 0.320 |
Why?
|
Sebum | 1 | 2009 | 17 | 0.320 |
Why?
|
Subcutaneous Fat, Abdominal | 1 | 2009 | 91 | 0.310 |
Why?
|
Electrocoagulation | 1 | 2008 | 157 | 0.280 |
Why?
|
Drug Delivery Systems | 3 | 2015 | 2207 | 0.280 |
Why?
|
Cicatrix | 4 | 2012 | 798 | 0.270 |
Why?
|
Skin Temperature | 1 | 2007 | 96 | 0.270 |
Why?
|
Ultrasonic Therapy | 1 | 2008 | 216 | 0.260 |
Why?
|
Melanosis | 1 | 2007 | 93 | 0.250 |
Why?
|
Periodicals as Topic | 1 | 2017 | 1462 | 0.250 |
Why?
|
Colonic Neoplasms | 1 | 2017 | 2531 | 0.250 |
Why?
|
Blood Pressure | 1 | 2021 | 8532 | 0.250 |
Why?
|
Thulium | 2 | 2022 | 21 | 0.240 |
Why?
|
Face | 2 | 2009 | 1028 | 0.240 |
Why?
|
Neutrophils | 1 | 2017 | 3776 | 0.230 |
Why?
|
Hemangioma | 1 | 2009 | 723 | 0.230 |
Why?
|
Administration, Cutaneous | 5 | 2024 | 715 | 0.220 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2017 | 3111 | 0.220 |
Why?
|
Forearm | 3 | 2021 | 427 | 0.220 |
Why?
|
Tissue Culture Techniques | 2 | 2018 | 286 | 0.220 |
Why?
|
Stress, Physiological | 1 | 2011 | 1402 | 0.210 |
Why?
|
Metalloporphyrins | 1 | 2022 | 41 | 0.210 |
Why?
|
Neoplasms, Unknown Primary | 1 | 2024 | 104 | 0.200 |
Why?
|
Cell Cycle | 1 | 2011 | 2920 | 0.200 |
Why?
|
Aging | 1 | 2021 | 8731 | 0.200 |
Why?
|
Disinfection | 1 | 2023 | 207 | 0.190 |
Why?
|
Wound Healing | 3 | 2024 | 2792 | 0.180 |
Why?
|
Hypertension | 1 | 2021 | 8626 | 0.180 |
Why?
|
Mice, Inbred BALB C | 4 | 2017 | 6220 | 0.180 |
Why?
|
DNA Damage | 1 | 2010 | 2457 | 0.170 |
Why?
|
Humans | 45 | 2024 | 765968 | 0.160 |
Why?
|
Cattle | 1 | 2024 | 3801 | 0.160 |
Why?
|
Ultraviolet Rays | 1 | 2023 | 1102 | 0.150 |
Why?
|
Melanoma | 3 | 2024 | 5719 | 0.150 |
Why?
|
3T3-L1 Cells | 1 | 2018 | 206 | 0.150 |
Why?
|
Dose-Response Relationship, Radiation | 2 | 2010 | 869 | 0.140 |
Why?
|
Skin Neoplasms | 2 | 2024 | 5849 | 0.140 |
Why?
|
Phenformin | 1 | 2017 | 15 | 0.140 |
Why?
|
Animals | 13 | 2024 | 168764 | 0.140 |
Why?
|
Pilot Projects | 3 | 2021 | 8733 | 0.130 |
Why?
|
Erythema | 3 | 2014 | 262 | 0.130 |
Why?
|
Neck | 1 | 2020 | 733 | 0.120 |
Why?
|
Neurofibromin 1 | 1 | 2017 | 190 | 0.120 |
Why?
|
Lymphocyte Count | 1 | 2017 | 790 | 0.120 |
Why?
|
Apoptosis | 2 | 2017 | 9514 | 0.120 |
Why?
|
Indazoles | 1 | 2017 | 303 | 0.120 |
Why?
|
Epitopes | 2 | 2021 | 2523 | 0.120 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2017 | 612 | 0.110 |
Why?
|
Female | 17 | 2024 | 396112 | 0.110 |
Why?
|
Fluorescein Angiography | 1 | 2019 | 1085 | 0.110 |
Why?
|
Singlet Oxygen | 1 | 2014 | 58 | 0.110 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2018 | 1333 | 0.100 |
Why?
|
Cell Survival | 3 | 2017 | 5747 | 0.100 |
Why?
|
Aminolevulinic Acid | 1 | 2014 | 147 | 0.100 |
Why?
|
Adaptive Immunity | 1 | 2017 | 734 | 0.100 |
Why?
|
Cell Line, Tumor | 3 | 2017 | 17075 | 0.100 |
Why?
|
Skin Diseases | 2 | 2014 | 1088 | 0.100 |
Why?
|
Disease Models, Animal | 3 | 2022 | 18293 | 0.090 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 1106 | 0.090 |
Why?
|
Spectrometry, Fluorescence | 1 | 2014 | 697 | 0.090 |
Why?
|
Tumor Burden | 1 | 2017 | 1885 | 0.090 |
Why?
|
Mice | 7 | 2022 | 81819 | 0.090 |
Why?
|
Adipose Tissue | 2 | 2017 | 3312 | 0.090 |
Why?
|
Adult | 11 | 2024 | 223044 | 0.090 |
Why?
|
Micronucleus Tests | 1 | 2010 | 23 | 0.090 |
Why?
|
Biopsy | 2 | 2015 | 6763 | 0.080 |
Why?
|
Photosensitizing Agents | 1 | 2014 | 625 | 0.080 |
Why?
|
Young Adult | 4 | 2024 | 59889 | 0.080 |
Why?
|
Lidocaine | 1 | 2012 | 550 | 0.080 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2012 | 538 | 0.080 |
Why?
|
Hyperpigmentation | 2 | 2007 | 117 | 0.080 |
Why?
|
Heat-Shock Response | 1 | 2010 | 179 | 0.080 |
Why?
|
Vaccines | 2 | 2014 | 841 | 0.080 |
Why?
|
Neoplasms | 1 | 2017 | 22340 | 0.080 |
Why?
|
Biophysical Phenomena | 1 | 2009 | 318 | 0.070 |
Why?
|
Forecasting | 1 | 2017 | 2936 | 0.070 |
Why?
|
Culture Media | 1 | 2010 | 890 | 0.070 |
Why?
|
Treatment Outcome | 4 | 2024 | 65188 | 0.070 |
Why?
|
Immunization | 1 | 2012 | 1219 | 0.070 |
Why?
|
Photochemotherapy | 1 | 2014 | 826 | 0.070 |
Why?
|
Energy Metabolism | 1 | 2018 | 2892 | 0.070 |
Why?
|
Piperazines | 1 | 2017 | 2549 | 0.060 |
Why?
|
Lentigo | 1 | 2006 | 37 | 0.060 |
Why?
|
Collagen Type III | 1 | 2006 | 92 | 0.060 |
Why?
|
Rejuvenation | 1 | 2007 | 109 | 0.060 |
Why?
|
Anesthetics, Local | 1 | 2012 | 1015 | 0.060 |
Why?
|
Cold Temperature | 1 | 2009 | 794 | 0.060 |
Why?
|
Docosahexaenoic Acids | 1 | 2012 | 916 | 0.060 |
Why?
|
Facial Dermatoses | 1 | 2006 | 87 | 0.060 |
Why?
|
Dermatitis | 1 | 2007 | 199 | 0.060 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2006 | 284 | 0.060 |
Why?
|
Male | 10 | 2024 | 363698 | 0.060 |
Why?
|
Survival Analysis | 1 | 2017 | 10070 | 0.060 |
Why?
|
Mitochondria | 1 | 2018 | 3673 | 0.060 |
Why?
|
Microscopy, Confocal | 2 | 2013 | 1966 | 0.060 |
Why?
|
Cadaver | 2 | 2007 | 1359 | 0.060 |
Why?
|
Disease Progression | 1 | 2021 | 13632 | 0.060 |
Why?
|
Mice, Inbred C57BL | 1 | 2022 | 22332 | 0.050 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2017 | 4642 | 0.050 |
Why?
|
Infrared Rays | 1 | 2005 | 246 | 0.050 |
Why?
|
Middle Aged | 9 | 2024 | 223009 | 0.050 |
Why?
|
Colitis | 1 | 2012 | 1239 | 0.050 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2006 | 393 | 0.050 |
Why?
|
Cell Division | 1 | 2011 | 4475 | 0.050 |
Why?
|
Models, Animal | 1 | 2009 | 2120 | 0.050 |
Why?
|
Rhodamines | 2 | 2014 | 178 | 0.050 |
Why?
|
Partial Pressure | 1 | 2022 | 245 | 0.050 |
Why?
|
Anti-Inflammatory Agents | 1 | 2012 | 1808 | 0.050 |
Why?
|
Cell Communication | 1 | 2010 | 1660 | 0.050 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2019 | 8923 | 0.050 |
Why?
|
Fever | 1 | 2010 | 1603 | 0.050 |
Why?
|
Aged | 5 | 2022 | 171117 | 0.050 |
Why?
|
Vaccination | 1 | 2014 | 3426 | 0.050 |
Why?
|
Equipment Design | 1 | 2010 | 3481 | 0.050 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2006 | 702 | 0.050 |
Why?
|
Necrosis | 1 | 2006 | 1617 | 0.050 |
Why?
|
Ovalbumin | 2 | 2014 | 674 | 0.050 |
Why?
|
Adolescent | 3 | 2024 | 88835 | 0.040 |
Why?
|
Hair Removal | 1 | 2001 | 41 | 0.040 |
Why?
|
Flow Cytometry | 1 | 2011 | 5881 | 0.040 |
Why?
|
Time Factors | 2 | 2015 | 40065 | 0.040 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2001 | 412 | 0.040 |
Why?
|
Eye | 1 | 2023 | 710 | 0.040 |
Why?
|
Cell Line | 2 | 2012 | 15543 | 0.040 |
Why?
|
Skin Pigmentation | 1 | 2001 | 279 | 0.040 |
Why?
|
Laser Coagulation | 1 | 2001 | 334 | 0.040 |
Why?
|
Actins | 1 | 2006 | 2056 | 0.040 |
Why?
|
Calorimetry, Differential Scanning | 1 | 2017 | 92 | 0.040 |
Why?
|
Phase Transition | 1 | 2017 | 73 | 0.040 |
Why?
|
Lipids | 1 | 2008 | 3315 | 0.040 |
Why?
|
Feasibility Studies | 1 | 2008 | 5302 | 0.040 |
Why?
|
Melanocytes | 1 | 2021 | 515 | 0.040 |
Why?
|
Communicable Disease Control | 1 | 2024 | 856 | 0.030 |
Why?
|
Macrophages | 1 | 2012 | 5772 | 0.030 |
Why?
|
Europe | 1 | 2024 | 3423 | 0.030 |
Why?
|
Regeneration | 1 | 2006 | 1517 | 0.030 |
Why?
|
Carbon Monoxide | 1 | 2020 | 560 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2021 | 59489 | 0.030 |
Why?
|
Air Pollution, Indoor | 1 | 2023 | 931 | 0.030 |
Why?
|
Obesity | 1 | 2018 | 13076 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2024 | 1084 | 0.030 |
Why?
|
Cells, Cultured | 1 | 2011 | 18973 | 0.030 |
Why?
|
Injections, Intradermal | 1 | 2014 | 116 | 0.030 |
Why?
|
Pain | 1 | 2009 | 5077 | 0.030 |
Why?
|
Cost of Illness | 1 | 2024 | 1950 | 0.030 |
Why?
|
Microinjections | 1 | 2014 | 320 | 0.030 |
Why?
|
Protoporphyrins | 1 | 2014 | 167 | 0.030 |
Why?
|
Dermabrasion | 1 | 2013 | 17 | 0.030 |
Why?
|
Cysteine-Rich Protein 61 | 1 | 2013 | 39 | 0.030 |
Why?
|
Drug Synergism | 1 | 2017 | 1749 | 0.030 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2017 | 750 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2006 | 11022 | 0.020 |
Why?
|
Injections, Intralesional | 1 | 2012 | 281 | 0.020 |
Why?
|
Methylene Blue | 1 | 2012 | 157 | 0.020 |
Why?
|
Tissue Array Analysis | 1 | 2013 | 545 | 0.020 |
Why?
|
Needles | 1 | 2014 | 460 | 0.020 |
Why?
|
Abdominal Wall | 1 | 2012 | 166 | 0.020 |
Why?
|
Temperature | 1 | 2017 | 2226 | 0.020 |
Why?
|
Oxygen | 1 | 2022 | 4241 | 0.020 |
Why?
|
Matrix Metalloproteinases | 1 | 2013 | 392 | 0.020 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2012 | 390 | 0.020 |
Why?
|
Oxygen Consumption | 1 | 2017 | 1870 | 0.020 |
Why?
|
Artifacts | 1 | 2019 | 1893 | 0.020 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2013 | 422 | 0.020 |
Why?
|
Kinetics | 1 | 2017 | 6274 | 0.020 |
Why?
|
Adjuvants, Immunologic | 1 | 2014 | 995 | 0.020 |
Why?
|
Wnt Proteins | 1 | 2013 | 722 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2012 | 1589 | 0.020 |
Why?
|
Cohort Studies | 1 | 2009 | 41649 | 0.020 |
Why?
|
Phagocytosis | 1 | 2012 | 1520 | 0.020 |
Why?
|
Antigens | 1 | 2012 | 1438 | 0.020 |
Why?
|
Electrons | 1 | 2006 | 265 | 0.020 |
Why?
|
Pigmentation Disorders | 1 | 2006 | 106 | 0.020 |
Why?
|
Collagen | 1 | 2013 | 2618 | 0.010 |
Why?
|
Up-Regulation | 1 | 2013 | 4137 | 0.010 |
Why?
|
Pandemics | 1 | 2024 | 8703 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2006 | 15747 | 0.010 |
Why?
|
Pressure | 1 | 2006 | 1168 | 0.010 |
Why?
|
Japan | 1 | 2006 | 1415 | 0.010 |
Why?
|
Congresses as Topic | 1 | 2006 | 811 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2013 | 4520 | 0.010 |
Why?
|
Histocytochemistry | 1 | 2001 | 696 | 0.010 |
Why?
|
Algorithms | 1 | 2019 | 14071 | 0.010 |
Why?
|
Prospective Studies | 3 | 2007 | 54802 | 0.010 |
Why?
|
Pain Measurement | 1 | 2007 | 3561 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2007 | 3475 | 0.010 |
Why?
|
Mutation | 1 | 2017 | 30198 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2017 | 36532 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2007 | 15880 | 0.000 |
Why?
|
Models, Biological | 1 | 2005 | 9443 | 0.000 |
Why?
|
Risk Factors | 1 | 2007 | 74840 | 0.000 |
Why?
|
Retrospective Studies | 1 | 2007 | 81514 | 0.000 |
Why?
|
Concepts
(235)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(32)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_